FDA Media Alert Detail

Drug Shortage

FDA Drug Shortage: Dextrose Monohydrate 50% Injection

  • U.S. Food and Drug Administration
  • August 24, 2026
  • ID: shortage-dextrose-monohydrate-50-injection-hospira-inc-a-pfizer-company-0409-7517-16

Drug Shortage Details

Generic NameDextrose Monohydrate 50% Injection
Manufacturer / CompanyHospira, Inc., a Pfizer Company
Therapeutic CategoryEndocrinology/Metabolism, Gastroenterology, Pediatric
Availability StatusAvailable
Status (FDA list)Current
NDC Package Code0409-7517-16
Presentation & Dosage Form

Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-7517-16)

Manufacturer Contact Info

844-646-4398


Content syndicated from the U.S. Food and Drug Administration (FDA) Drug Shortages Database.